185 related articles for article (PubMed ID: 32963617)
1. High ADAMTS18 expression is associated with poor prognosis in stomach adenocarcinoma.
Jiang K; Li L; Xie Y; Xie D; Xiao Q
Oncol Lett; 2020 Nov; 20(5):211. PubMed ID: 32963617
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination.
You W; Ouyang J; Cai Z; Chen Y; Wu X
Front Immunol; 2022; 13():827506. PubMed ID: 35874675
[TBL] [Abstract][Full Text] [Related]
3. Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas.
Wang X; Zhang W; Guo Y; Zhang Y; Bai X; Xie Y
World J Surg Oncol; 2023 Feb; 21(1):61. PubMed ID: 36823639
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive bioinformatic analysis of mind bomb 1 gene in stomach adenocarcinoma.
Wang D; Wang QH; Luo T; Jia W; Wang J
World J Gastrointest Oncol; 2023 Jul; 15(7):1295-1310. PubMed ID: 37546549
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of COMMD10 as a novel prognostic biomarker for gastric cancer.
Zhao W; Lin J; Cheng S; Li H; Shu Y; Xu C
PeerJ; 2023; 11():e14645. PubMed ID: 36919165
[TBL] [Abstract][Full Text] [Related]
6. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
Gu J; Li Y; Fan L; Zhao Q; Tan B; Hua K; Wu G
Oncotarget; 2017 Jul; 8(30):49201-49216. PubMed ID: 28484081
[TBL] [Abstract][Full Text] [Related]
7. Analysis of IGFBP7 expression characteristics in pan-cancer and its clinical relevance to stomach adenocarcinoma.
Xu HW; Wang MQ; Zhu SL
Transl Cancer Res; 2023 Oct; 12(10):2596-2612. PubMed ID: 37969374
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Age Acceleration of Stomach Adenocarcinoma Associated With Tumor Stemness Features, Immunoactivation, and Favorable Prognosis.
Hong C; Yang S; Wang Q; Zhang S; Wu W; Chen J; Zhong D; Li M; Li L; Li J; Yu H; Chen H; Zeng Q; Zhang C
Front Genet; 2021; 12():563051. PubMed ID: 33815458
[No Abstract] [Full Text] [Related]
9. Inhibition of ITGB1-DT expression delays the growth and migration of stomach adenocarcinoma and improves the prognosis of cancer patients using the bioinformatics and cell model analysis.
Jiang N; Guo Q; Luo Q
J Gastrointest Oncol; 2022 Apr; 13(2):615-629. PubMed ID: 35557569
[TBL] [Abstract][Full Text] [Related]
10. PLVAP protein expression correlated with microbial composition, clinicopathological features, and prognosis of patients with stomach adenocarcinoma.
Wen Y; Wang Y; Huang Y; Liu Z; Hui C
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7139-7153. PubMed ID: 36884119
[TBL] [Abstract][Full Text] [Related]
11. MAGED4B is a Poor Prognostic Marker of Stomach Adenocarcinoma and a Potential Therapeutic Target for Stomach Adenocarcinoma Tumorigenesis.
Luo WZ; Li X; Wu XX; Shang YW; Meng DH; Chen YL; Zhang QS
Int J Gen Med; 2023; 16():1681-1693. PubMed ID: 37181643
[TBL] [Abstract][Full Text] [Related]
12. Analysis of expression profile of miRNA in stomach adenocarcinoma.
Huo Q
J BUON; 2017; 22(5):1154-1159. PubMed ID: 29135097
[TBL] [Abstract][Full Text] [Related]
13. Potential Prognostic Value and Mechanism of Stromal-Immune Signature in Tumor Microenvironment for Stomach Adenocarcinoma.
Zhu X; Xie X; Zhao Q; Zhang L; Li C; Zhao D
Biomed Res Int; 2020; 2020():4673153. PubMed ID: 32685487
[TBL] [Abstract][Full Text] [Related]
14. Increased
Zhaoran S; Linnebacher CS; Linnebacher M
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046730
[TBL] [Abstract][Full Text] [Related]
15. WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma.
Yuan Q; Zhou Q; Ren J; Wang G; Yin C; Shang D; Xia S
Cancer Med; 2021 Jun; 10(12):4004-4016. PubMed ID: 33982398
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of ADAMTS18 May Serve as a Poor Prognostic Biomarker for Cervical Cancer Patients.
Zhang L; Liu Y; Zheng P
Appl Immunohistochem Mol Morphol; 2018 Oct; 26(9):670-675. PubMed ID: 28362704
[TBL] [Abstract][Full Text] [Related]
17. Identification of the key genes controlling stomach adenocarcinoma stem cell characteristics via an analysis of stemness indices.
Wang G; Wu Z; Huang Y; Li Y; Bai Y; Luo Z; Huang W; Chen Z
J Gastrointest Oncol; 2022 Apr; 13(2):593-604. PubMed ID: 35557559
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic value of APOBEC2 in gastric adenocarcinoma and its association with tumor-infiltrating immune cells.
Wei L; Wu X; Wang L; Chen L; Wu X; Song T; Wang Y; Chang W; Guo A; Niu Y; Huang H
BMC Cancer; 2024 Jan; 24(1):15. PubMed ID: 38166744
[TBL] [Abstract][Full Text] [Related]
19. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
20. Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer.
Zhang T; Lai S; Cai Y; Huang Z; Li Y; Chen S; Zhang Z; Ye Z; Lai X; Zhai E; Cai S; Chen J
Front Cell Dev Biol; 2021; 9():719613. PubMed ID: 34869310
[No Abstract] [Full Text] [Related]
[Next] [New Search]
